Stock listing
NASDAQ:RAPP Rapport Therapeutics, Inc. Stock
Home listing (NASDAQ) of Rapport Therapeutics, Inc.
Follow Rapport Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RAPP
$25.13 USD +0.08 (+0.3%)
Close on Nov 2, 2026
- Day range
- $24.22 – $26.16 USDNov 2, 2026
- Volume
- 1.33M sharesNov 2, 2026
- Market cap
- $1.21B USDAt the close on Nov 2, 2026 · price × 47.98M shares outstanding
- 52-week range
- $22.06 – $52.93 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $22.61M USDMedian day 324,500 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RAPP · Home | $25.13 USD | +0.08 (+0.3%) | 1,327,415 | $25.16 | $26.16 | $24.22 | $25.05 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:RAPP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $25.13 | +0.08 | +0.3% | $25.16 | $26.16 | $24.22 | 1,327,415 | |
| $25.05 | +0.84 | +3.5% | $23.94 | $25.43 | $23.86 | 922,247 | |
| $24.21 | +1.71 | +7.6% | $22.58 | $25.76 | $22.58 | 3,094,708 | |
| $22.50 | -5.04 | -18.3% | $22.59 | $23.94 | $22.06 | 5,940,919 | |
| $27.54 | +2.21 | +8.7% | $25.11 | $28.31 | $25.11 | 601,911 | |
| $25.33 | -0.60 | -2.3% | $26.02 | $27.95 | $25.10 | 1,040,733 | |
| $25.93 | -0.60 | -2.3% | $27.54 | $27.76 | $25.71 | 1,185,000 | |
| $26.53 | +1.47 | +5.9% | $26.17 | $27.89 | $25.81 | 1,458,200 | |
| $25.06 | -4.31 | -14.7% | $29.91 | $29.91 | $24.69 | 2,158,300 | |
| $29.37 | +0.77 | +2.7% | $30.33 | $31.31 | $26.73 | 8,200,200 | |
| $28.60 | +1.03 | +3.7% | $27.57 | $29.10 | $27.57 | 299,900 | |
| $27.57 | -2.00 | -6.8% | $29.50 | $29.75 | $26.93 | 412,100 | |
| $29.57 | +1.24 | +4.4% | $29.12 | $30.48 | $28.68 | 334,900 | |
| $28.33 | -0.66 | -2.3% | $28.71 | $29.31 | $28.10 | 304,000 | |
| $28.99 | -1.16 | -3.8% | $30.00 | $30.01 | $28.68 | 310,000 | |
| $30.15 | -0.50 | -1.6% | $30.65 | $30.99 | $30.00 | 127,100 | |
| $30.65 | +0.80 | +2.7% | $29.73 | $31.20 | $29.50 | 247,900 | |
| $29.85 | -1.01 | -3.3% | $30.62 | $30.62 | $29.45 | 236,800 | |
| $30.86 | -0.29 | -0.9% | $30.81 | $31.35 | $30.46 | 315,000 | |
| $31.15 | -1.04 | -3.2% | $32.92 | $34.00 | $30.01 | 235,600 | |
| $32.19 | +0.02 | +0.1% | $32.22 | $32.71 | $31.53 | 198,500 | |
| $32.17 | -0.66 | -2.0% | $33.33 | $34.48 | $31.77 | 276,300 | |
| $32.83 | -0.77 | -2.3% | $33.52 | $34.32 | $32.80 | 326,800 | |
| $33.60 | +0.58 | +1.8% | $33.17 | $34.05 | $32.62 | 581,700 | |
| $33.02 | -0.42 | -1.3% | $33.25 | $33.66 | $32.12 | 626,100 | |
| $33.44 | -0.47 | -1.4% | $33.48 | $34.00 | $32.36 | 552,300 | |
| $33.91 | +0.08 | +0.2% | $33.80 | $34.89 | $33.05 | 711,800 | |
| $33.83 | -0.30 | -0.9% | $34.15 | $34.21 | $31.58 | 848,500 | |
| $34.13 | -7.34 | -17.7% | $41.01 | $41.47 | $33.38 | 743,700 | |
| $41.47 | +1.81 | +4.6% | $39.97 | $41.55 | $37.94 | 900,200 | |
| $39.66 | -0.79 | -2.0% | $40.70 | $42.18 | $39.11 | 617,000 | |
| $40.45 | -1.50 | -3.6% | $41.89 | $43.00 | $40.29 | 998,100 | |
| $41.95 | +0.56 | +1.4% | $42.13 | $42.90 | $41.39 | 397,300 | |
| $41.39 | -1.29 | -3.0% | $42.82 | $43.67 | $41.23 | 387,000 | |
| $42.68 | -1.32 | -3.0% | $43.87 | $43.98 | $41.76 | 189,300 | |
| $44.00 | +0.38 | +0.9% | $44.30 | $44.90 | $43.36 | 196,900 | |
| $43.62 | +0.16 | +0.4% | $44.21 | $44.30 | $43.01 | 251,800 | |
| $43.46 | -0.425 | -1.0% | $43.35 | $44.00 | $42.65 | 319,300 | |
| $43.89 | -2.205 | -4.8% | $45.17 | $45.42 | $43.13 | 437,700 | |
| $46.09 | +0.32 | +0.7% | $45.01 | $47.00 | $44.67 | 489,400 | |
| $45.77 | -1.88 | -3.9% | $47.63 | $48.00 | $45.52 | 279,900 | |
| $47.65 | -1.04 | -2.1% | $48.85 | $49.14 | $47.08 | 277,000 | |
| $48.69 | +0.13 | +0.3% | $48.50 | $50.34 | $47.73 | 294,700 | |
| $48.56 | -0.11 | -0.2% | $48.17 | $49.38 | $47.90 | 148,600 | |
| $48.67 | -0.10 | -0.2% | $48.72 | $49.33 | $47.51 | 221,000 | |
| $48.77 | -2.06 | -4.1% | $50.15 | $50.68 | $48.37 | 332,700 | |
| $50.83 | -1.67 | -3.2% | $51.88 | $52.93 | $50.60 | 382,800 | |
| $52.50 | +1.33 | +2.6% | $50.95 | $52.83 | $50.01 | 275,300 | |
| $51.17 | +1.84 | +3.7% | $49.88 | $51.38 | $49.00 | 324,500 | |
| $49.33 | +1.09 | +2.3% | $48.16 | $50.34 | $47.44 | 365,422 | |
| $48.24 | +0.39 | +0.8% | $48.36 | $48.50 | $47.48 | 140,900 | |
| $47.85 | -1.22 | -2.5% | $48.58 | $48.78 | $47.00 | 323,700 | |
| $49.07 | +0.06 | +0.1% | $49.58 | $49.90 | $48.62 | 232,300 | |
| $49.01 | +0.59 | +1.2% | $47.81 | $49.37 | $47.73 | 214,700 | |
| $48.42 | +1.00 | +2.1% | $47.42 | $49.03 | $47.26 | 203,900 | |
| $47.42 | +0.06 | +0.1% | $47.00 | $47.64 | $46.37 | 159,800 | |
| $47.36 | -0.37 | -0.8% | $48.41 | $48.48 | $46.96 | 242,100 | |
| $47.73 | -1.09 | -2.2% | $49.00 | $49.50 | $46.76 | 316,900 | |
| $48.82 | +1.84 | +3.9% | $47.16 | $48.94 | $46.35 | 425,300 | |
| $46.98 | +1.49 | +3.3% | $45.60 | $47.17 | $45.30 | 265,800 | |
| $45.49 | -0.86 | -1.9% | $47.00 | $48.00 | $44.91 | 246,100 | |
| $46.35 | +3.91 | +9.2% | $42.99 | $46.72 | $42.85 | 408,400 | |
| $42.44 | +0.24 | +0.6% | $41.43 | $42.77 | $40.69 | 210,100 | |
| $42.20 | +1.41 | +3.5% | $41.27 | $42.57 | $40.75 | 398,000 | |
| $40.79 | -0.19 | -0.5% | $40.78 | $42.10 | $39.75 | 315,200 |
- Ticker
- NASDAQ:RAPP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Latest deck · Oct 20, 2026
Corporate Update (October 2026)
Corporate update · 26 slides
Latest news
Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement
Oct 28, 2026
Closed $22.50 (-18.3%) on Oct 28, 2026
Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement
Oct 27, 2026
Closed $22.50 (-18.3%) on Oct 28, 2026
Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania
Oct 20, 2026
Closed $29.37 (+2.7%) on Oct 20, 2026
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
Aug 24, 2026
Closed $49.33 (+2.3%) on Aug 24, 2026
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
Aug 5, 2026
Closed $42.44 (+0.6%) on Aug 5, 2026
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026
Closed $36.70 (+2.7%) on May 21, 2026
Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
May 7, 2026
Closed $39.93 (+7.7%) on May 7, 2026
Financings
Public offering of common stock and pre-funded warrants
Oct 28, 2026
Update: about US$175M · US$21 a share · Morgan Stanley +4
Dealers: Morgan Stanley (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), BTIG (co-lead), Citizens Capital Markets (co-lead)
Use of proceeds: Fund clinical trials of RAP-219, other research and development, working capital and general corporate purposes
2.25% convertible senior notes due 2032
Oct 28, 2026
Update: US$150M · Morgan Stanley +2
Dealers: Morgan Stanley (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead)
Use of proceeds: Fund clinical trials of RAP-219, other research and development, working capital and general corporate purposes
Private placement of common stock
Oct 28, 2026
Update: about US$30M · US$21 a share · Morgan Stanley +2
Dealers: Morgan Stanley, Leerink Partners, Evercore ISI
Use of proceeds: Fund clinical trials of RAP-219, other research and development, working capital and general corporate purposes
Decks
Corporate Update (October 2026)
Corporate update · 26 slides · Oct 20, 2026
Investor Presentation (August 2026)
Investor deck · 51 slides · August 2026
American Academy of Neurology Annual Meeting 2026
Conference · 13 slides · Apr 21, 2026
Investor Presentation (April 2026)
Investor deck · 50 slides · Apr 21, 2026
Rapport Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 42 in all · newest Nov 3, 2026 · oldest 2024
- Decks
- 11 decks · latest Oct 20, 2026
Where Rapport Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RAPP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:RAPP | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Rapport Therapeutics, Inc.